ArticleIrish journal of medical science2026
The psychometric properties of the 3-m backward walk test in people with Migraine.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe objective of the study was to examine the test–retest reliability of the 3-m backward walk test (3MBWT), the minimum detectable change (MDC) in the 3MBWT, the concurrent and known-groups validity of the 3MBWT in people with migraine (PwM), and the cut-off time which best discriminate PwM from healthy people.
methodsThis was a cross-sectional study. Forty-seven PwM and 47 healthy people were recruited. The 3MBWT was performed along with the cervical joint position sense test, Fremantle Neck Awareness Questionnaire, Berg Balance Scale, timed up and go test, and numeric pain rating scale.
resultsThe 3MBWT showed excellent test–retest reliability (ICC = 0.907–0.971). The MDC was 0.76 s. The 3MBWT had fair-to-strong correlations with the other measurements. Significant differences in the 3MBWT times were found between PwM and healthy people (p < 0.001). The 3MBWT time of 4.09 s was determined to best discriminate PwM from healthy people.
conclusionsThe 3MBWT is a reliable, valid, and clinically available measurement tool in assessing the backward walking performance for PwM. It can detect deficits in backward walking performance and is associated with disease-specific impairments in migraine.
Indexed as
Identifiers
41317294What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.